Recommended Treatment for Rosacea
Treatment for rosacea should be phenotype-led, with specific therapies targeted to the patient's predominant features (erythema, papules/pustules, phymatous changes, or ocular manifestations). 1
General Approach
- General skincare forms the foundation of rosacea management, including sun protection (SPF 30+), gentle cleansers, moisturizers, and trigger avoidance 1, 2
- Treatment should be allowed sufficient time (6-12 weeks) before considering it a failure 1
- Combination therapy is often necessary for moderate to severe presentations 1
- Maintenance therapy should use the minimum treatment necessary to maintain control 1
Treatment by Phenotype
Transient Erythema (Flushing)
- Topical α-adrenergics (brimonidine) 1
- Oral beta blockers 1, 3
- Pulsed-dye laser (PDL) 1, 3
- Oral doxycycline 1
Persistent Erythema
Inflammatory Papules/Pustules
- Mild: Topical azelaic acid 15%, ivermectin 1%, or metronidazole 0.75% 1, 2, 5
- Moderate: Same topicals as for mild, plus oral doxycycline 1, 4
- Severe: Topical ivermectin, oral doxycycline, or oral isotretinoin 1, 6
Telangiectasia
Phymatous Changes
- Clinically inflamed: Oral doxycycline 1
- Clinically noninflamed: Physical modalities (laser therapy, surgical correction) 1, 3
Ocular Rosacea
- Lid hygiene for mild cases 2, 4
- Artificial tear substitutes for mild ocular burning/stinging 1
- Oral doxycycline for moderate to severe cases 2, 4
- Referral to ophthalmologist for cases that cannot be controlled with lid hygiene 1
Medication Details
Topical Treatments
- Azelaic acid 15%: Effective for mild inflammatory papules/pustules and reduces erythema 7, 5
- Caution: May cause temporary skin irritation, especially on broken skin 7
- Metronidazole 0.75-1%: Effective for mild to moderate papulopustular rosacea 5, 4
- Ivermectin 1%: Effective for inflammatory lesions 2, 6
- Brimonidine tartrate 0.5%: Specifically reduces persistent facial erythema 3, 4
Oral Treatments
- Doxycycline: Effective for moderate to severe inflammatory lesions, ocular rosacea, and clinically inflamed phyma 1
- Available as standard doses (≥50mg) with antibiotic activity or as 40mg modified-release with anti-inflammatory but not antibiotic activity 1
- Isotretinoin: Reserved for severe papulopustular rosacea 1, 6
Common Pitfalls and Caveats
- Insufficient treatment duration is a common mistake; studies shorter than 8 weeks may inadequately demonstrate efficacy 1
- Ocular rosacea is often overlooked but requires specific management 1, 4
- Topical corticosteroids should be avoided as they can worsen rosacea or cause steroid rosacea 8
- Without maintenance therapy, up to two-thirds of patients may relapse 2
- Patients with dark complexions should report abnormal changes in skin color when using azelaic acid 7
Special Considerations
- Moderate and severe presentations typically require combination therapy rather than monotherapy 1
- If first-line treatment fails, consider an alternative first-line option or add another first-line agent 1
- Referral to specialists is necessary for severe or recalcitrant rosacea, phymatous changes, or ocular rosacea with ophthalmic complications 5